Biological Aging Accelerated by Radiation Treatment in Breast Cancer Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 45(17):1,8, September 5, 2023. Favorite PDF Permissions Free
Results of Patritumab Deruxtecan in Metastatic Breast Cancer Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 45(16):20, August 20, 2023. Favorite PDF Permissions Free
Sacituzumab Govitecan Shows Survival Benefit in Metastatic Breast Cancer Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 45(16):6, August 20, 2023. Favorite PDF Permissions Free
The Futility of Preoperative MRI Screening in Lumpectomy Patients Galamba, Elizabeth Rose Galamba, Elizabeth Rose Less Oncology Times. 45(15):16, August 5, 2023. Favorite PDF Permissions Free
A Look at Tailored Exercise & Wellness Programs for Breast Cancer DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 45(15):12-13, August 5, 2023. Favorite PDF Permissions Free
Cancer Screening Disparities Among Hispanic Individuals DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 45(15):1,9, August 5, 2023. Favorite PDF Permissions Free
3 QUESTIONS ON . . . Strategies for Finding Cancers in Women With Dense Breasts: With Wendie Berg, MD, PhD, at the University of Pittsburgh School of Medicine and Magee-Womens Hospital of UPMC DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 45(14):26, July 20, 2023. Favorite PDF Permissions Free
Is It Time to Reconsider Intraoperative Lymph Node Pathology? Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 45(14):18, July 20, 2023. Favorite PDF Permissions Free
Ribociclib + Endocrine Therapy Reduces Recurrence Risk in Breast Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 45(13):16, July 5, 2023. Favorite PDF Permissions Free
A Closer Look at Personalized Cancer Screening & Recommendations Jenks, Susan Jenks, Susan Less Oncology Times. 45(13):13,25, July 5, 2023. Favorite PDF Permissions Free
Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 45(13):12, July 5, 2023. Favorite PDF Permissions Free
3 QUESTIONS ON . . . Using Artificial Intelligence in Breast Cancer Risk Prediction: With Celine Vachon, PhD, Professor of Epidemiology in the Department of Quantitative Health Sciences at Mayo Clinic DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 45(12):26, June 20, 2023. Favorite PDF Permissions Free
Oncodrivers for Immunotherapies in Triple-Negative Breast Cancer Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 45(12):18, June 20, 2023. Favorite PDF Permissions Free
Providers Respond to USPSTF Report on Screening for Breast Cancer Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 45(12):16-17, June 20, 2023. Favorite PDF Permissions Free
Exploring Microbes in Breast Tumors From Women of Different Races Nalley, Catlin Nalley, Catlin Less Oncology Times. 45(12):10-11, June 20, 2023. Favorite PDF Permissions Free CME Test
New Draft Recommendation on Breast Cancer Screening Less Oncology Times. 45(11):13, June 5, 2023. Favorite PDF Permissions Free
Racial Disparities in Women at High Risk for Breast Cancer Galamba, Elizabeth Rose Galamba, Elizabeth Rose Less Oncology Times. 45(10):21-22, May 20, 2023. Favorite PDF Permissions Free
Low Rates of Early Detection Drive Excess Breast Cancer Mortality Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 45(10):20,22, May 20, 2023. Favorite PDF Permissions Free
FDA Enhances National Standards to Protect Breast Health Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 45(10):1,12, May 20, 2023. Favorite PDF Permissions Free
3 QUESTIONS ON . . . Risk-Stratified Follow-Up Guidelines in Breast Cancer Care: With Heather B. Neuman, MD, MS, FACS, at the University of Wisconsin School of Medicine & Public Health DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 45(8):26, April 20, 2023. Favorite PDF Permissions Free
Potential Strategy to Prevent Late Recurrence of ER+ Breast Cancer Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 45(8):23, April 20, 2023. Favorite PDF Permissions Free
Breast Cancer Treatment Outcomes for Sex & Gender Minority Patients DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 45(8):1,13,20, April 20, 2023. Favorite PDF Permissions Free
Social Determinants Found in Breast Cancer Disparity Less Oncology Times. 45(7):18, April 5, 2023. Favorite PDF Permissions Free
3 QUESTIONS ON... Addressing Disparities in Breast Cancer Treatment Delays: With Katherine Reeder-Hayes, MD, MSc, MBA, Associate Professor of Medicine-Oncology and Section Chief of Breast Oncology at UNC Lineberger Comprehensive Cancer Center DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 45(5):38, March 5, 2023. Favorite PDF Permissions Free
The Cost Challenges of MRIs for Breast Cancer Screening Galamba, Elizabeth Rose Galamba, Elizabeth Rose Less Oncology Times. 45(5):20, March 5, 2023. Favorite PDF Permissions Free
Delays in Diagnosis for Young Adult Patients With Breast Cancer DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 45(5):1,11,16, March 5, 2023. Favorite PDF Permissions Free
Acupuncture for Breast Cancer Survivors With Chronic Pain DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 45(4):20, February 20, 2023. Favorite PDF Permissions Free
Film Dressing Reduces Acute Radiation Dermatitis in Breast Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 45(3):30, February 5, 2023. Favorite PDF Permissions Free
WISDOM Study: Annual Mammograms vs. Personalized Approach Jenks, Susan Jenks, Susan Less Oncology Times. 45(3):28, February 5, 2023. Favorite PDF Permissions Free
Treatment of Early-Stage Breast Cancer During Pregnancy Froelich, Warren Froelich, Warren Less Oncology Times. 45(2):23, January 20, 2023. Favorite PDF Permissions Free
Genetic Profiling in Patients After Breast-Conserving Surgery McGraw, Mark McGraw, Mark Less Oncology Times. 45(2):22, January 20, 2023. Favorite PDF Permissions Free
RxPONDER Trial Examines Breast Cancer Therapy Outcomes for Black Women McGraw, Mark McGraw, Mark Less Oncology Times. 45(2):21, January 20, 2023. Favorite PDF Permissions Free
Ribociclib + Endocrine Therapy in HR+/HER2- Advanced Breast Cancer Froelich, Warren Froelich, Warren Less Oncology Times. 45(2):20, January 20, 2023. Favorite PDF Permissions Free
Why Black Women With Breast Cancer Experience Worse Outcomes Froelich, Warren Froelich, Warren Less Oncology Times. 45(2):19, January 20, 2023. Favorite PDF Permissions Free
Risk Factors for Thoracic Soft Tissue Sarcomas in Breast Cancer Survivors Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 45(2):1,9,12, January 20, 2023. Favorite PDF Permissions Free
High Deductibles Lead Women to Skip Testing After Abnormal Mammogram McGraw, Mark McGraw, Mark Less Oncology Times. 45(1):33, January 5, 2023. Favorite PDF Permissions Free
The Relationship Between the Microbiome & Breast Cancer Nalley, Catlin Nalley, Catlin Less Oncology Times. 45(1):26, January 5, 2023. Favorite PDF Permissions Free
PARP Inhibitor Therapy for Breast Cancer With PALB2 Mutations Wolfgang, Kelly Wolfgang, Kelly Less Oncology Times. 45(1):23, January 5, 2023. Favorite PDF Permissions Free
New Multi-Center Analysis Investigates Invasive Lobular Carcinoma Outcomes Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 44(24):30-31, December 20, 2022. Favorite PDF Permissions Free
Use of Ipatasertib in Patients Who Present With AKT Mutation Tumors Froelich, Warren Froelich, Warren Less Oncology Times. 44(23):35, December 5, 2022. Favorite PDF Permissions Free
Three-Week Radiation Course Effective for Early-Stage Breast Cancer McGraw, Mark McGraw, Mark Less Oncology Times. 44(23):29, December 5, 2022. Favorite PDF Permissions Free
Adjuvant Palbociclib Provides No Benefit for Stage IIA Breast Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 44(23):14, December 5, 2022. Favorite PDF Permissions Free
The Mechanistic Association Between Obesity & Breast Cancer Wolfgang, Kelly Wolfgang, Kelly Less Oncology Times. 44(23):1,15, December 5, 2022. Favorite PDF Permissions Free
TIM-3 Regulates Extracellular DNA Uptake & Response to Chemotherapy Gallagher, Amy Gallagher, Amy Less Oncology Times. 44(22):35, November 20, 2022. Favorite PDF Permissions Free
Radiographers Could Help With Double Reading of Mammograms McGraw, Mark McGraw, Mark Less Oncology Times. 44(22):29, November 20, 2022. Favorite PDF Permissions Free
Two-Pronged Imaging May Help Dense Breast Cancer Detection Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 44(22):24-25, November 20, 2022. Favorite PDF Permissions Free
The Link Between African Ancestry & Triple-Negative Breast Cancer Froelich, Warren Froelich, Warren Less Oncology Times. 44(22):1,17, November 20, 2022. Favorite PDF Permissions Free
Could AI Assistance Improve Breast Cancer Screening Accuracy? McGraw, Mark McGraw, Mark Less Oncology Times. 44(21):20, November 5, 2022. Favorite PDF Permissions Free
Differences in Neoadjuvant Endocrine Therapy for Black & White Women Froelich, Warren Froelich, Warren Less Oncology Times. 44(21):12, November 5, 2022. Favorite PDF Permissions Free
3 QUESTIONS ON... Optimizing Cost-Effectiveness of Chemo for Metastatic Breast Cancer: With Stephanie Wheeler, PhD, MPH, of the UNC Lineberger Comprehensive Cancer Center DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 44(19):26, October 5, 2022. Favorite PDF Permissions Free
Molecule Targets Vulnerability in Triple-Negative Breast Cancer Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 44(19):19, October 5, 2022. Favorite PDF Permissions Free
Implementation Hurdles to Closing the Gap in Breast Cancer Survivorship Care DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 44(18):1,5, September 20, 2022. Favorite PDF Permissions Free
Annual Mammograms for Older Breast Cancer Survivors McGraw, Mark McGraw, Mark Less Oncology Times. 44(17):12, September 5, 2022. Favorite PDF Permissions Free
Early & Metastatic Breast Cancer Patients Prefer At-Home Treatments Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 44(16):15, August 20, 2022. Favorite PDF Permissions Free
Screening Mammography Volumes Yet to Return to Pre-Pandemic Levels McGraw, Mark McGraw, Mark Less Oncology Times. 44(15):26, August 5, 2022. Favorite PDF Permissions Free
Avoiding Radiation Therapy for Low-Grade Luminal A-Type Breast Cancer Froelich, Warren Froelich, Warren Less Oncology Times. 44(15):20, August 5, 2022. Favorite PDF Permissions Free
Sacituzumab Govitecan Could Provide New Metastatic Breast Cancer Option Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 44(15):19, August 5, 2022. Favorite PDF Permissions Free
Accurate Diagnostic Mammography Outcomes Vary By Race/Ethnicity Gallagher, Amy Gallagher, Amy Less Oncology Times. 44(15):11, August 5, 2022. Favorite PDF Permissions Free
DESTINY-Breast04 Offers New Standard for Metastatic Breast Cancer Froelich, Warren Froelich, Warren Less Oncology Times. 44(14):25,29, July 20, 2022. Favorite PDF Permissions Free
Breast Cancer Survivors Lost Weight With Telemedicine Support Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 44(14):24, July 20, 2022. Favorite PDF Permissions Free
Musings of a Cancer Doctor Breast Cancer at ASCO 2022: Some Big (and Smaller) Steps Forward Sledge, George W. Jr. Sledge, George W. Jr. Less Oncology Times. 44(14):18-19, July 20, 2022. Favorite PDF Permissions Free
Multidisciplinary Teams Can Help Breast Cancer Survivors Start Families Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 44(13):25, July 5, 2022. Favorite PDF Permissions Free
Converting Immunologically ‘Cold’ Breast Tumors Into ‘Hot’ Ones Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 44(13):24, July 5, 2022. Favorite PDF Permissions Free
Many Black Patients With Metastatic Breast Cancer Not Offered Clinical Trials Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 44(13):20, July 5, 2022. Favorite PDF Permissions Free
Could Liquid Biopsies Bring Early Warning of Breast Cancer Relapse? Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 44(13):19, July 5, 2022. Favorite PDF Permissions Free
Multidisciplinary Precision Extends Life in Oligometastatic Breast Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 44(12):18,23, June 20, 2022. Favorite PDF Permissions Free
Patient-Reported Outcomes Support First-Line Pembrolizumab in TNBC Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 44(12):17, June 20, 2022. Favorite PDF Permissions Free
Lower Screening Rates for Women Who Have Breast Cancer Along With MS McGraw, Mark McGraw, Mark Less Oncology Times. 44(12):15, June 20, 2022. Favorite PDF Permissions Free
Breast Cancer Trial Looks to Recruit Underserved Communities Gallagher, Amy Gallagher, Amy Less Oncology Times. 44(12):13-14, June 20, 2022. Favorite PDF Permissions Free
The Importance of Examining Recurrent Ductal Carcinoma in Situ of the Breast Froelich, Warren Froelich, Warren Less Oncology Times. 44(10):26, May 20, 2022. Favorite PDF Permissions Free
HER2-Positive Breast Cancer Treatments Are Rapidly Evolving Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 44(10):19-20, May 20, 2022. Favorite PDF Permissions Free CME Test
Lumpectomy Just as Effective in Young Breast Cancer Patient Survival Samson, Kurt Samson, Kurt Less Oncology Times. 44(9):23, May 5, 2022. Favorite PDF Permissions Free
Study Challenges the Need for Node Biopsies for Most Older Women Samson, Kurt Samson, Kurt Less Oncology Times. 44(9):22, May 5, 2022. Favorite PDF Permissions Free
COVID-19 Severely Delayed Breast Cancer Care at Urban Hospital Samson, Kurt Samson, Kurt Less Oncology Times. 44(9):21, May 5, 2022. Favorite PDF Permissions Free
Phase I Trial Tests Vaccine for Use in Triple-Negative Breast Cancer Jenks, Susan Jenks, Susan Less Oncology Times. 44(9):17, May 5, 2022. Favorite PDF Permissions Free
Personalized Immunotherapy Shows Promise in Metastatic Breast Cancer Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 44(8):28, April 20, 2022. Favorite PDF Permissions Free
The Association of Breast Cancer Risk & Sweetened Beverages Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 44(8):19-20, April 20, 2022. Favorite PDF Permissions Free CME Test
Daily Aspirin Fails to Prevent Breast Cancer Recurrence Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 44(7):30, April 5, 2022. Favorite PDF Permissions Free
Breast Cancer Top Cause of Cancer Death for Black Women Schneider, Mary Ellen Schneider, Mary Ellen Less Oncology Times. 44(7):29, April 5, 2022. Favorite PDF Permissions Free
Racial Disparities in Breast Cancer Survival at the Molecular Level Froelich, Warren Froelich, Warren Less Oncology Times. 44(6):32, March 20, 2022. Favorite PDF Permissions Free
Radiologist Experience, Fatigue Affect Breast Imaging Interpretation McGraw, Mark McGraw, Mark Less Oncology Times. 44(6):27, March 20, 2022. Favorite PDF Permissions Free
MRI May Lower Breast Cancer Deaths From Variants in Three Genes Less Oncology Times. 44(6):11, March 20, 2022. Favorite PDF Permissions Free
3 QUESTIONS ON... Prospective Lymphedema Surveillance for Patients With Breast Cancer: With Bolette Rafn, PT, PhD, of the Cancer Survivorship and Treatment Late Effects Research Unit in the Department of Oncology at Copenhagen University Hospital DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 44(5):38, March 5, 2022. Favorite PDF Permissions Free
With Personalized Medicine, a Shelved Cancer Drug Could Get Another Shot Less Oncology Times. 44(5):27, March 5, 2022. Favorite PDF Permissions Free
Depression Screening Implementation for Breast Cancer Patients Galamba, Elizabeth Rose Galamba, Elizabeth Rose Less Oncology Times. 44(5):26, March 5, 2022. Favorite PDF Permissions Free
High-Risk Breast Cancer Patients Not Getting Supplemental MRI McGraw, Mark McGraw, Mark Less Oncology Times. 44(5):25, March 5, 2022. Favorite PDF Permissions Free
3 QUESTIONS ON... Cardiometabolic Risk Factors in Breast Cancer Survivors: With Marilyn Kwan, PhD, Senior Research Scientist in the Division of Research at Kaiser Permanente Northern California DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 44(4):38, February 20, 2022. Favorite PDF Permissions Free
Evidence-Based Integrative Therapies: Hypnosis for Breast Cancer Gallagher, Amy Gallagher, Amy Less Oncology Times. 44(4):34, February 20, 2022. Favorite PDF Permissions Free
Questioning Chemotherapy Benefits in Invasive Lobular Breast Cancer Gallagher, Amy Gallagher, Amy Less Oncology Times. 44(4):33, February 20, 2022. Favorite PDF Permissions Free
TNBC: Identifying Co-Alterations of the PI3K & DDR Pathway Genes Gallagher, Amy Gallagher, Amy Less Oncology Times. 44(4):32, February 20, 2022. Favorite PDF Permissions Free
3 QUESTIONS ON... Genetic Counseling & Testing in African-American Patients With Breast Cancer: With Foluso Ademuyiwa, MD, MPH, MSCI, Associate Professor of Medicine at Washington University School of Medicine DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 44(3):34, February 5, 2022. Favorite PDF Permissions Free
Understanding Factors Influencing Immune Cells & Breast Cancer Gallagher, Amy Gallagher, Amy Less Oncology Times. 44(3):31, February 5, 2022. Favorite PDF Permissions Free
Investigating an Increased Uterine Cancer Risk in Breast Cancer Patients Froelich, Warren Froelich, Warren Less Oncology Times. 44(3):30, February 5, 2022. Favorite PDF Permissions Free
Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases Gallagher, Amy Gallagher, Amy Less Oncology Times. 44(3):29, February 5, 2022. Favorite PDF Permissions Free
Selecting Rational Biomarkers for Clinical & Translational Studies Gallagher, Amy Gallagher, Amy Less Oncology Times. 44(3):28, February 5, 2022. Favorite PDF Permissions Free
Breast Cancer Diagnosis & Treatment Before vs. During COVID-19 Pandemic Gallagher, Amy Gallagher, Amy Less Oncology Times. 44(3):27, February 5, 2022. Favorite PDF Permissions Free
Tumor Biology, Not Race, More Significant in Predicting Response Froelich, Warren Froelich, Warren Less Oncology Times. 44(3):26-27, February 5, 2022. Favorite PDF Permissions Free
Radiation Therapy in Oligoprogressive NSCLC & Breast Cancer Holt, Chuck Holt, Chuck Less Oncology Times. 44(3):17,24, February 5, 2022. Favorite PDF Permissions Free
Elacestrant Provides Greater PFS for Breast Cancer Patients Froelich, Warren Froelich, Warren Less Oncology Times. 44(2):28, January 20, 2022. Favorite PDF Permissions Free
The Greater Risk of Lymphedema in Black Women With Breast Cancer Froelich, Warren Froelich, Warren Less Oncology Times. 44(2):27, January 20, 2022. Favorite PDF Permissions Free
